TAM
CMD

Tiverton Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Tiverton Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,680
Closed -$458K – 754
2019
Q2 		$458K Buy
5,680
+1,702
+43% +$120K 0.02% 400
2019
Q1 		$266K Buy
+3,978
New +$301K 0.01% 496

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Tiverton Asset Management's CMD Position: Q3 2019 in Review

Tiverton Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 5,680 shares — an estimated $458K sold.

Tiverton Asset Management first reported a position in CMD in Q1 2019 and held it in 2 quarters. The position peaked at $458K in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Tiverton Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
  • Tiverton Asset Management sold 5,680 Cantel Medical Corporation shares in Q3 2019, an estimated $458K.
  • Tiverton Asset Management first reported a position in Cantel Medical Corporation in Q1 2019 and held it in 2 quarters.
  • Tiverton Asset Management's Cantel Medical Corporation position peaked at $458K in Q2 2019.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.